Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Cohance Lifesciences Ltd.
NSE: COHANCE
|
BSE: 543064
|
ISIN: INE03QK01018
|
Industry: Pharmaceuticals
|
Expensive Underperformer
293.4500
-2.65
(
-0.89
%)
NSE
Mar 16, 2026
15:31 PM
New 52W Low in past week
Volume:
604.1K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Cohance Lifesciences Ltd.
15 Mar 2023
293.45
-0.89%
SUVEN PHARMACEUTICALS LIMITED
Hold:
Cohance Lifesciences Ltd.
by
Geojit BNP Paribas
Target: 504
Target
Geojit BNP Paribas
Number of MF schemes decreased from 30 to 24 in Dec 2025 qtr
More from Cohance Lifesciences Ltd.
Recommended
IPO market remains active despite weak retail demand and a volatile market
|
16 Mar 2026, 05:41PM
Market closes higher on gains in banking, auto, and cement stocks
Trendlyne Marketwatch |
16 Mar 2026, 04:14PM
Five Interesting Stocks Today - March 13, 2026
The Baseline |
13 Mar 2026